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SumlTlal~ 
We have introduced long precursor peptides directly into the endoplasmic reticulum (ER) of 
a mutant cell line (T2-D  b) that lacks the ability  to transport peptides from the cytosol to the 
ER in a transporter associated with antigen processing (TAP)-dependent way. This was done 
by expressing various  influenza A-derived peptides containing the naturally processed epitope 
ASNENMDAM (366-374) preceded by the influenza hemagglutinin ER translocation sequence. 
Peptides  derived from these  minigenes that became associated  with  D b were  isolated  and 
identified by combined reversed phase liquid chromatography and detection by cytotoxic T lym- 
phocytes.  Our results establish  that NH2-terminal extensions of at least  40 residues  can be 
trimmed from peptides entering the ER, but that proteolysis of larger proteins may be limited. 
C 
TLs  recognize peptide epitopes of 8-10 amino acids, 
bound to polymorphic receptors encoded by the major 
histocompatibility complex (1-3).  The MHC peptide/class 
I complex is formed in the endoplasmic reticulum (ER) 1 be- 
fore it translocates to the call surface. Peptide binding to newly 
synthesized class I molecules is an integral part of the stable 
assembly of the MHC molecule itself and may be a prerequi- 
site for transit of the complex to the cell surface (4,  5). 
The production of most peptides destined for presenta- 
tion by class I MHC begins in the cytosol with the limited 
hydrolysis of antigenic proteins. The proteases  involved in 
this step have not yet been identified, but attention has re- 
cently focused on the proteasome- a multicatalytic complex 
in the cytosol with one ATP-dependent proteolytic activity, 
specific for ubiquitinated substrates, and three ATP-indepen- 
dent activities  (6). The involvement of the former activity 
in antigen processing has been implied in two experimental 
systems (7, 8). To date, there is no evidence that proteasomes 
generate peptides of a size that is optimal for binding to class 
I. However, recent investigations into the regulation of pro- 
teasome specificity by its two MHC-encoded subunits has 
led to the speculation that proteasomes may generate pep- 
tides with COOH termini that are appropriate for binding 
1 Abbreviations used in this paper: ~2m, B2-microglobin;  BFA, brefeldin A; 
ER,  endoplasmic reticulum; HA, hemagglutinin; NP,  nucleoprotein; 
RPLC, reverse phase liquid chromatography;  TAP, transporter associated 
with antigen processing  complex; TBS, Tris-buffered  saline; TLCK, Nct- 
p-tosyl-t-chloromethyl ketone. 
to class I (9, 10) and that these may be trimmed in the ER 
at their NH2 termini, as suggested by Falk et al.  (11). 
The topological paradox posed by the observations that 
peptide production and peptide binding to class I occur in 
two distinct intraceltular compartments can be resolved only 
if there exists a mechanism for translocating peptides across 
the ER membrane in a signal sequence-independent  way (12, 
13). Recently, a polymorphic, heterodimeric protein encoded 
in the MHC class II region has been identified that fulfills 
this function (14-17). The complex, known as TAP (trans- 
porter associated with antigen processing [reviewed in refer- 
ence 18]), belongs to a family of ATP-binding cassette pro- 
teins and has been shown to transport peptides from the 
cytosolic to the lumenal side of the ER membrane in an ATP- 
dependent way (19, 20). 
The processes by which short peptides are selected for pre- 
sentation at the cell surface are not fully understood. There 
is ample evidence for the involvement of the class I molecule 
itself in selecting peptides, with which it forms the most stable 
complexes,  during  the  assembly  of  the  heavy  chain:3z 
microglobin (~zm):peptide heterotrimer (11 and reviewed in 
reference 21). However, the observation that few of the total 
number of class I-binding peptides that could be generated 
from any given viral protein are actually  selected for use as 
epitopes suggests that other processes could contribute to 
epitope selection in vivo. This notion is supported by examples 
in which different peptide epitopes are presented by the same 
class I molecule depending on the cellular context in which 
that class I molecule is expressed (22). Attention has there- 
fore turned to the influence of proteases and the peptide trans- 
porters on selecting peptides for class I binding. 
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amino acids can be efficiently transported into the ER. The 
first  indication for this came from the demonstration that 
peptides of up to 11 amino acids, derived from cytosolic and 
nuclear proteins could be isolated from class I molecules (23). 
In addition, Udaka et al. (24) have isolated a 16-amino acid 
peptide from H-2L  a that is derived from the cytosolicaUy 
synthesized enzyme 2-oxoglutarate dehydrogenase and that 
is recognized by allospecific CTLs. Recently, direct measure- 
ments of the ATP-dependent transport function of the TAP 
complex have been made (19,  20).  These show that long 
peptides (up to 23 amino acids)  are capable of competing 
against shorter peptides for transport (20).  Further indirect 
evidence for the transport of long peptides by the TAP com- 
plex has come from Eisenlohr et al.  (25), who have shown 
that an H-2Kb-restricted epitope could be generated from 
a 12-amino acid precursor synthesized as a minigene only 
if (a) an appropriate proteolytic enzyme specificity was co- 
expressed in the ER and (b) the TAP complex was functional. 
These results could be explained only if the longer precursor 
peptide was translocated into the ER by the TAP complex, 
followed by cleavage  to the nonamer. 
We demonstrate here that in ceils lacking TAP proteins, 
large fragments of influenza nucleoprotein (NP) translocated 
into the ER via a hydrophobic signal sequence can be trimmed 
to the authentic 9-residue epitope recognized by CTLs. At 
least 40 amino acids between the signal sequence and the epi- 
tope can be removed, although larger extensions inhibit trim- 
ming.  These results establish  that an NH2-terminal trim- 
ruing mechanism does exist in the ER lumen and show that 
assembly of the resulting short peptide with class I mole- 
cules under these conditions can occur in the absence of the 
TAP proteins. 
Materials and Methods 
Cells, Antibodies and Peptides.  The TAP-defective  cell line T2 
was transfected with H-2D  b and H-2K  k as previously described 
(26). Murine L and L-D  b cells were maintained in RPMI 1640 plus 
10% FCS (R10) as described previously (1). CTL clone F5 recog- 
nizes the Db-restricted  influenza NP epitope ASNENMDAM (cor- 
responding to residues 366-374),  as well as longer peptides con- 
taining this core sequence (1, 3). HA8 is a CTL clone derived by 
Gould et al. (27) that recognizes the hemagglutinin (HA)-derived 
peptide  IEGGWTGMI  (HA1  residues 354-362)  restricted  by 
H-2K  k (27). A polyclonal CTL line recognizing the Kk-restricted 
influenza NP epitope SDYEGRLI (50-57) was generated from the 
splenocytes  of CBA mice infected with influenza strain E61-13-H17 
(H17) and restimulated in vitro with NP50-57 as previously de- 
scribed (28). 
The mAb B22.249, specific for the o~1 domain of H-2D  b, has 
been described previously (29). This antibody has been shown to 
stabilize the interaction between D r heavy chain and ~/2m (30, 31) 
and, when bound to peptide: D b complexes, slows the rate of dis- 
sociation of bound peptides by around  10-fold (32). 
Peptides  MQIASNENMDAM,  QIASNENMDAM,  IAS- 
NENMDAM,  and ASNENMDAM  were synthesized manually 
using fmoc chemistry. Cleavage and deprotection was with TFA. 
Peptides were purified by ether precipitation followed by reverse 
phase liquid chromatography (RPI.C). Peptides IEGGWTGMI and 
SDYEGRLI were prepared commercially. All peptides used in this 
investigation were judged to be >95% pure by HPLC. Determi- 
nation of peptide concentration was by colorimetric assay (BCA; 
Pierce, Rockford,  IL). 
Recombinant Vaccinias.  Recombinant vaccinias were made by ho- 
mologous recombination into the thymidine kinase gene using the 
shuttle  vector psc11.30R.2. This was constructed  by blunt-end 
cloning a synthetic polylinker into the SmaI site of psc11 (33) con- 
taining the Kozak sequence, NcoI (containing the ATG codon), 
SmaI, and StuI sites in two additional reading frames, followed 
by stop codons in all three reading frames (34). Vaccinias were 
propagated in tk143 cells and isolated  by standard procedures. Virus 
titers were determined on monolayers of tk143 cells. The recom- 
binant genes introduced into vaccinia for use in this investigation 
are shown in Fig. 1. 
psc11L+M366 and psc11L+M364 were made by first cloning a 
synthetic minigene coding for the HA-1 leader sequence MKA- 
NLLVLLCALAAADA into the unique NcoI site of psc11.30R.2 
in such a way as to preserve a unique NcoI site immediately 3' 
of the inserted leader sequence. The orientation and sequence of 
the new plasmid (pscllL+) were confirmed by dideoxy sequencing. 
Oligos encoding either MASNENMDAM or MQIASNENMDAM 
were constructed with a 5' NcoI site (encoding Met at position 1) 
and a BamHI site at the 3' end. These were cloned into NcoI/BgllI- 
cut psc11L+, psc11L+  NP was made in a similar way, by ligating 
the NcoI-SalI fragment of ptac85-NP (7) containing the full-length 
influenza NP with NcoI/SmaI-cut psc11L+, after creating a blunt 
end at the 3' end of NP. psc11L+  IMP was made by cloning a syn- 
thetic minigene coding for MKANLLVLLCALAAADAMNAT, 
which contains the HA leader sequence, into the EcoRI/Pvull- 
cleaved fragment of ptac85-NP (7). The EcoRI-SalI fragment of 
this plasmid containing  the leader plus residues 328-498  of NP 
was  then blunt-end  cloned into SmaI-cut psc11. Generation  of 
365-379 vacc, IMP vacc, and NP vacc have been described pre- 
viously (7, 35). 
CTL Assays.  4-h CTL assays were performed using a standard 
protocol. When sensitization by recombinant vaccinias was tested, 
106 target cells were incubated with 5  x  106 PFU of virus and 
20/~Ci  of 5~Cr (as sodium chromate) for 1 h at 37~  The cell 
pellet was then washed twice with R10, resuspended in 200/zl 
of the same, and incubated for an additional 2.5-3 h at 37~  After 
three washes with R10, cells were dispensed at  10,000 cells per 
well for use in the assay. For influenza  infection, targets were washed 
three times in PBS before infection with 200/zl of allantoic fluid 
containing  influenza E61-13-H17 virus in  the presence of SlCr. 
When peptides were tested, they were added to target and effector 
cells and were present throughout the CTL assay. When pharmaco- 
logical interference with processing was tested, target cells were 
labeled and then preincubated with either 0.5/zg of brefeldin A 
(BFA) or 80 #M chloroquine for 20 min at room temperature be- 
fore the addition of virus. They were then washed with R10 made 
either 1 #M BFA or 60/~M chloroquine before infection in the 
same. CTL assays were performed in the presence of 1/~M BFA 
or 5 /~M chloroquine. 
Large-Scale Infection of Cells and Immunoprecipitation of D b  from 
Infected Cells.  For peptide elution experiments, 109 T2-D  b or L-D  b 
cells were harvested and resuspended in RPMI 1640 supplemented 
with glutamine at a final concentration of 108 cells per ml, in the 
presence of 5  x  109 PFU of the appropriate purified vaccinia. 
After 2 h at 37~  with continual rolling, the cell pellet was washed 
once with R10, resuspended in 50 ml of the same, and incubated 
on a roller platform for 4-6 h at 37~  (Expression of vaccinia- 
encoded genes was confirmed by monitoring 3-galactosidase ex- 
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Figure 1.  Constructs used in this investigation. The 
vaccinia shuttle vector  psc11.30Ik.2  containing  L+ NP (a), 
L+IMP (b), L+ M364-374 (c), and L+M366-374 (d) were 
used to  make recombinant vaccinias as  described in 
Materials and Methods. 
pression in aliquots of 2  x  105 cells that were incubated with 
6 mg/ml X-Gal for 1 h at 37~  after being lysed  in 100/A of  double- 
distilled H20. The supernatant was monitored for absorbance at 
405 nm. Typically, infected cells reached a plateau of expression 
at OD 1.0-2.0 after around 2 h (wild-type infected cells gave an 
OD of 0.2). The cell pellet was then harvested, washed twice in 
ice-cold Tris-buffered saline (TBS), and immediately lysed by the 
addition of 5 ml of ice-cold TBS containing 1% NP-40, protease 
inhibitors (5 mM EDTA, PMSF, iodoacetamide,  50/~g/ml antipain, 
2/~g/ml aprotinin,  40 #g/ml bestatin,  100/~g/ml  chymostatin, 
10/xg/ml E-64, 0.5/~g/ml leupeptin,  0.7/xg/ml pepstatin,  and 
Nc~-p-tosyl-L-chloromethyl  ketone [TLCK]), and 1 mg of purified 
B22.249. After 2 h at 4~  with continual agitation, the lysate was 
centrifuged at 15,000 rpm, and the cleared supernatant was har- 
vested. 2 ml of a 10% suspension of protein A-Sepharose 4B in 
TBS, 1% NP-40 was added, and incubation was continued for an 
additional 1 h at 4~  The immunoprecipitate was then washed 
twice in 10 ml of  TBS, 1% NP-40 and four times in 10 mM ammo- 
nium acetate, pH 7.5 at 4~ 
Extraction and Analysis of Peptides Bound to D b.  Washed  precipi- 
tates were incubated for 5 min at room temperature with 0.1% 
TFA or 10% acetic acid in water. Protein A-Sepharose beads were 
removed by filtration through a 0.45-/~m membrane, and low mo- 
lecular weight material (<10,000) was isolated by membrane filtra- 
tion chromatography (Centricon C10; Amicon Corp., Beverly,  MA). 
Samples of 1-2 ml recovered  in this way were applied to a C8 micro- 
bore RPLC (Applied Biosystems, Inc., Foster City, CA) column 
without further processing and fractionated by gradient  elution 
(2-50% acetonitrile in 0.07% TFA at a rate of 1% per min fol- 
lowed by 50-90% at a rate of 2% per min) at a flow rate of 0.2 
ml/min. 1-min fractions  were collected  and immediately  dried under 
vacuum. 200/A of RPMI 1640 was added to each tube, and 50 
/A of the redissolved fraction was tested in duplicate for its ability 
to sensitize labeled T2-D  b for lysis by clone F5. In addition, each 
fraction was tested in duplicate for its toxicity to target cells in 
the absence of specific CTLs. 
lmmunopreciFitation of NP.  5  x  106 T2-D  b cells were infected 
for 1 h with 1.5  x  107 PFU of L+NP-vacc or bNP-vacc, in 100 
/A of methionine-free RPMI supplemented with 10% FCS. 50/~Ci 
of [35S]methionine was then added to each aliquot of cells, and 
metabolic labeling was allowed to proceed for 30 min at 37~ 
Cells were then lysed in 0.5 ml of cold "Iris buffer, pH 7.4, con- 
taining 0.5% NP-40 and 0.5% Mega-9 (Sigma Immunochemicals, 
St. Louis, MO), and the lysates were precleared overnight with 
fixed Staphylococcus aureus. Immunoprecipitation  of NP was per- 
formed the following day using the anti-influenza A NP mAb 14- 
7-18 as described previously (12). Endoglycosidase H digestion of 
immunoprecipitates was performed by resuspending the immuno- 
precipitate in 30/~1 of 50 mM sodium citrate buffer, pH 5.5, con- 
taining 0.2% SDS, heating to 95~  for 5 min, and adding 2 U 
of endoglycodidase H after cooling to 37~  Digestion was per- 
formed at 37~  for 18 h before resolving the immunoprecipitates 
on a 10% gel. 
Results 
NH2-Terminal  Trimming  Occurs  in  the ER  of TAP-deficient 
Cells.  The immunodominant Db-restricted epitope of influ- 
enza A virus is the nonamer ASNENMDAM, corresponding 
to residues 366-374 of the NP (1, 3). This peptide has been 
isolated from D b molecules purified from lysates of influenza- 
infected cells (3).  We have shown previously that 366-374 
binds to D b with a half-life of >200 h at 4~  and that pep- 
tides extended at the NH2 terminus also bind but with an 
intermediate rate of dissociation, around 20 h at 4~  for the 
decamer Y366-374.  By contrast, peptides extended at the 
COOH terminus dissociated 10-fold faster than those extended 
at  the  NH2  terminus  (32).  These results  were consistent 
with the proposal by Rotszchke et al.  (3) that peptides ex- 
tended at the NH2 terminus may bind to class I molecules 
in the ER,  albeit with low affinity, before trimming. 
To determine whether peptides longer than the optimal 
nonameric epitope can be trimmed by ER enzymes to pro- 
duce the optimal peptide, we constructed recombinant vac- 
cinia  viruses  containing  minigenes  encoding  either  the 
10-amino acid peptide MASNENMDAM or the 12-amino 
acid peptide MQIASNENMDAM,  tagged with the signal 
sequence derived from  influenza A/PR/8/34  HA  (called 
L+ M366-vacc and L+ M364-vacc; see Fig.  1). Addition of a 
hydrophobic signal sequence has been shown to be an efficient 
way of by-passing the TAP defect in T2 (36). Fig. 2 b shows 
that  these  vaccinias  were  as  efficient  in  sensitizing  L-D  b 
target cells for lysis by the CTL clone F5 as the minigenes 
synthesized  without  a  leader  sequence  (L-M366-vacc  and 
L-365-379-vacc). However, only those peptides expressed with 
the HA leader sequence were able  to sensitize T2-D  b cells 
for lysis by F5 (Fig.  2 d), indicating that efficient delivery 
of the  peptide  products  to  D b molecules was  dependent 
on the presence of the ER translocation sequence in a cell 
line that lacks  a functional TAP complex. This established 
that the fragments must have been translocated with their 
NH2-terminal extensions intact. 
We next asked whether the predominant epitope recog- 
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Figure 2.  Sensitization of target cells with L+peptide-vacc. 
The ability of clone F5 to lyse either IcD  b (a and b) or T2- 
D b (c and d) cells was tested after preincubation with either 
synthetic peptide 366-374 (a and c) or recombinant vaccinias 
(b  and  d)  encoding  L+M366-374  (0),  M366-374  (O), 
L+M364-374  (am), M365-379  ([]]),  or HIV-pol (O).  The 
E/T ratio in a  and c was  2:1. 
nized by F5 under these conditions corresponded to the se- 
quence encoded by the minigene,  or whether further pro- 
cessing of the NH2-terminal extended peptides had occurred 
in the ER. We isolated peptides associated with D b after in- 
fection with the appropriate recombinant vaccinia and iden- 
tified the predominant epitope according to its characteristic 
retention time upon RPLC fractionation.  First, each poten- 
tial product, MQIASNENMDAM, QIASNENMDAM, IAS- 
NENMDAM,  and  ASNENMDAM,  was  synthesized  and 
was shown to give a characteristic retention time when ana- 
lyzed by RPLC. The relative ability of each peptide to sensi- 
tize T2-D b in  a CTL assay was also determined.  Fig.  3 a 
shows that  the naturally  processed peptide 366-374  sensi- 
tized T2-D b cells to half-maximal lysis at a concentration of 
I pM. To our surprise, M364-374 was as effective, followed 
by 365-374 and 364-374,  which was over 10,000-fold less 
potent. These results indicate that successful detection of both 
M364-374 and 366-374 could be achieved by the recovery 
of each peptide from infected cells in the femtomolar range. 
The method for purifying Db-bound peptides was chosen to 
ensure that loss of peptides with a short half-life of dissocia- 
tion was minimal  (see Materials  and Methods). 
Fig.  3  c  and  d  show  that  after  infection  with  either 
L+M366-374  or  L+M364-374,  only  the  nonamer  AS- 
NENMDAM could be recovered from D b, indicating  that 
the longer precursors, introduced directly into the ER of T2, 
had been trimmed to the optimal epitope. No intermediate 
sized peptides were identified. The control infection with wild- 
type vaccinia WR (Fig.  3 b) did not give rise to any peptide 
capable of sensitizing  T2-D b cells. 
ER Proteases Are Capable of Generating Optimal Epitopes 
from Large Polypeptide  Precursors. To see whether ER proteol- 
ysis was limited to the trimming of a small number of amino 
acids from the NH2 termini of long precursor peptides, or 
whether the same optimal epitope could be derived from a 
much larger precursor, recombinant vaccinias were constructed 
that encoded a 170-amino  acid COOH-terminal  fragment 
of NP (residues 328-498, referred to as IMP) with and without 
the HA leader sequence (termed L+ IMP and DIMP, respec- 
tively,  see Fig. 1). We were unable to detect the presence of 
this fragment after infection of T2-D  b cells with L+ IMP by 
immunoprecipitation  or Western blotting.  The IMP frag- 
ment expressed without the leader sequence can be detected 
by immunoprecipitation  and has been shown to be rapidly 
degraded in the cytosol (7). Lack of detection of L+ IMP most 
probably therefore reflects  its very short half-life  when ex- 
pressed with the ER translocation sequence. Other proteins 
that have been inappropriately expressed in the ER after ex- 
perimental manipulation  have been shown to have half-lives 
on the order of minutes, even though they are relatively stable 
when expressed in their native compartment  (37).  Despite 
the lack of biochemical evidence for expression, Fig. 4 shows 
that sensitization of bD b cells by L+ IMP was as e~cient as 
that by L-IMP, indicating that IMP was efficiently expressed 
by the L+ minigene construct. Furthermore,  sensitization of 
T2-D b cells by L+ IMP-vacc was ef~cient and was dependent 
on the presence of the leader sequence. 
Isolation of peptides associated  with D b from L+ IMP-in- 
fected T2-D b cells was performed to determine the nature 
of the epitope derived from this polypeptide. Fig. 4 shows 
that a major species corresponding to ASNENMDAM was 
identified.  Thus,  again,  the major product  of intracellular 
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Figure  3.  Characterization of peptides associated with D b isolated from 
recombinant  vaccinia-infected  T2-D  b  cells. (a)  Titration  curves  for 
366-374,  365-374,  364-374,  and M366-374  and their characteristic reten- 
tion times on RPI.C. Detection of peptides by clone F5 (e) was tested 
after fractionation  of peptides  associated with Db from T2-D  b cells in- 
fected with wild-type vaccinia (b), L+ M366-374 vacc (c), and L+ M364-374 
vacc (d). In addition, the nonspecific  toxicity of each fraction was tested (O). 
proteolysis was the nonamer corresponding to the optimal 
binding peptide. These results show that proteolysis in the 
ER can give rise to an optimal CTL epitope contained within 
a 170-amino acid polypeptide, in which the epitope is ~40 
residues from the NH2  terminus. 
In addition, fraction 58 sensitized T2-D  b cells for lysis in 
a CTL-dependent way, though this was not reproducible when 
the experiment was repeated. In the experiment shown in 
Fig. 4, we were unable to determine the origin of this ac- 
tivity, though the possibility that it represented an intermediate 
of proteolysis cannot be ruled out. 
Trimming Does Not Occur Extracellularly.  Since the pre- 
cursor peptides expressed with the ER translocation signal 
were all introduced directly into the secretory pathway, it 
was possible  that the trimming we observed could have oc- 
curred in the extracellular space during infection, followed 
by binding to D b at the cell surface. To rule out this possi- 
bility, we coincubated 51Cr-labeled T2-D  b cells with unla- 
beled T2 cells that had been infected with L+vacc. Coincu- 
bation was performed for 4-6 h under the same conditions 
as those used for infection before the isolation of D b. This 
mixture of cells was then exposed to clone F5 in a 4-h CTL 
assay. The labeled, uninfected T2-D b ceils were not sensi- 
tized for lysis after coincubation with infected T2 cells even 
when the latter were present at a 10-fold excess. In the same 
experiment, T2-D  b cells were sensitized for lysis by infec- 
tion under the same conditions and by incubation with added 
peptides down to a concentration of 0.1 pM (data not shown). 
Another explanation for the observed trimming of precursor 
peptides was that they were degraded in vitro after lysing 
the infected cells, before immunoprecipitation. We addressed 
this possibility by lysing 109 T2-D  b cells in the presence of 
2/xM crude M364-374.  D b molecules were immunopurified. 
After washing the immunoprecipitate and eluting bound pep- 
tides,  the peptide mixture was fractionated by RPLC,  and 
each fraction was tested for its ability to sensitize T2-D  b cells 
for lysis by clone F5. Fig. 5 shows that the predominant peak 
of CTL activity resided in fractions coeluting with RPLC- 
purified M364-374.  A small peak of activity was also seen 
in fraction 20,  which almost certainly represents the pres- 
ence of some 366-374.  (This was confirmed by performing 
the same experiment with 2/zM 366-374 in the lysate,  in 
which a large peak of activity was recovered from immuno- 
purified D b in fractions spanning 20;  see Fig.  5.) Some of 
this material was already present in the M366-374 prepara- 
tion, since the same peak of activity was detected when the 
peptide was fractionated by RPLC and each fraction was tested 
(data not shown)￿9 Inclusion of protease inhibitors in the lysis 
buffer was therefore sufficient to prevent the complete degra- 
dation of M364-374 during the peptide isolation procedure. 
Taken together, these results indicate that  the recovery of 
366-374 from L+ M364-374-infected cells was a consequence 
of intraceUular processing before lysis. 
Intracellular Processing of  L+ Constructs Occurs in a BFA-sensitive, 
Chtoroquine-insensitive Compartment.  BFA causes a redistri- 
bution of intracellular compartments such that the medial 
and c/s-Golgi cisternae collapse into the ER, whereas the trans- 
Golgi network fuses with the recycling endosomal system 
(38). It therefore blocks class I-restricted presentation of in- 
tracellular antigens by inhibiting the egress of newly formed 
class I:peptide complexes from the ER to the trans-Golgi net- 
work (39, 40)￿9 We tested the ability of BFA to interfere with 
the  processing  and  presentation  of  vaccinia-encoded 
L+M364-374 and L+IMP. Fig.  6 b shows that 1/xM BFA 
was sufficient to block presentation of these polypeptides by 
T2-D b cells. Inhibition of presentation of both the L+  and 
L-polypeptides in L-D  b cells,  which has  a functional TAP 
complex, was also observed (Fig.  6 a). 
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Figure  4.  Sensitization of target cells with L+ IMP and du- 
tion  of  peptides  from  L+IMP-infected T2-D b cells.  The 
ability of clone F5 to lyse either L-D  b (a) or T2-D  b (b) cells 
was tested after infection with recombinant vaccinias encoding 
L+IMP (e), IMP (O), or HIV-pol (O). (c) Peptides  assodated 
with D b from T2-D b cells infected  with L+IMP  were ffac- 
tionated and tested for their ability to sensitize clone F5 (O) 
or to lyse T2-D  b cells  nonspecifically  (O). 
Leader-dependent, intracellular processing of antigens for 
presentation with MHC class II has been described previ- 
ously (41, 42), and has been shown to occur in low pH com- 
partments, by the ability of cloroquine to inhibit antigen pro- 
cessing.  Although  the  requirement for newly  synthesized 
MHC molecules was not demonstrated by these investiga- 
tions, we felt that it was necessary to investigate the role of 
low  pH  compartments  in  generating  epitopes  from  our 
L+constructs.  Fig.  6 shows that chloroquine  had no effect 
on the processing and presentation of L+ M364 and L+ IMP 
in T2-D  b cells (or in  the control  cell line L-Db). 
Taken together, these results are consistent with the trim- 
ming of precursor polypeptides and the association of trimmed 
products with newly synthesized class I molecules occurring 
in a pre-trans-Gol~ compartment and most likely the lumen 
of the ER. 
CTL Epitopes Are Not Generated  from the ER Degradation 
of  Full-Length Proteins.  It is unclear whether CTL epitopes 
o  io  20  30  4o  5o  eo  70 
Fraction  number 
Figure  5.  Trimming is not due to extracellular  processing.  Little in vitro 
degradation  of M366-374  occurs  after  cell lysis.  T2-D b cells were lysed 
in  the  presence  of 366-374  (e)  or M364-374  (O),  and peptides bound 
to D b were  eluted  and fractionated  by RPLC. 
Figure  6.  The  ability  of L-D  b  (a)  and  T2-D  b  (b)  cells  to  process 
L+M366-374  vacc, L+M364-374 vacc,  and L+IMP  vacc and to present 
synthetic 366-374  to clone F5  in the absence  of drugs  (open bars) or in 
the  presence  of BFA (dashed bars) or chloroquine  (hatched Mrs). 
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observation that CTL epitopes appear to be derived mainly 
from nonglycoproteins and the demonstration that peptides 
derived from glycoproteins and secreted proteins occur rarely 
in eluates from purified class I molecules (see reference 21 
for a summary) suggest that glycoproteins are protected from 
the action of ER proteases. 
We have investigated the role of ER proteases  in the pro- 
cessing of glycoproteins in two ways.  First,  the processing 
of influenza A HA was investigated in T2-K  k. Fig. 7 shows 
that the HA epitope IEGGWTGMI (corresponding to residues 
354-362  of HA1),  recognized by  the KLrestricted  clone 
HA8 (27),  was not generated in T2-K  k cells when the an- 
tigen, was delivered after influenza (PRS) infection or infec- 
tion with recombinant vaccinias  encoding full-length HA 
(1-565) or a truncated HA (1-413)  (27), even though L-D  b 
cells were sensitized for lysis by all three. Thus, HA and the 
truncated fragment did not appear to be susceptible to ER 
degradation in  the same way as L+ IMP. 
In a second approach, we constructed a recombinant vac- 
cinia encoding full-length influenza NP, tagged with the HA 
leader sequence (L+ NP-vacc).  Infection of T2-D  b cells with 
this vaccinia and immunoprecipitation of NP from a pulse- 
labeled lysate indicated that the majority of NP migrated more 
slowly than L-NP when analyzed by SDS-PAGE,  and was 
sensitive to endoglycosidase H (Fig. 8). These results are con- 
sistent with the cotranslational transport of newly synthe- 
sized NP into the ER and the glycosylation of cryptic se- 
quons (NAT and NDT)  at positions  21  and  144. 
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Figure  7.  Sensitization  of target  cells with endogenous  influenza HA 
for lysis by clone HA8. L (a and b) and T2-K  k (c and d) cells were sensi- 
tive to lysis by added peptide 354-362 (a and c) and were tested for their 
ability  to process and present  this peptide  after infection with influenza 
A PR8 (V), HA vacc (e), KG26 vacc encoding the HA truncation 1-413 
(11),  and  HIV-pol vacc (A). 
Figure  8.  Detection of NP in 
recombinant vaccinia-infected  T2- 
D b cells. T2-D  b  cells  were  in- 
fected with L+ NP-vacc (lanes a 
and b) or L-NP-vacc (lanes c and 
d),  and  NP was  detected  1.5  h 
after infection by immunoprecip- 
itation.  Immunoprecipitates were 
either treated  with endoglycosi- 
dase H  (lanes b and d) or mock 
digested  (lanes a and c). 
The ability of ER proteases to generate two well-charac- 
terized CTL epitopes from L+NP  was then tested.  Fig.  9 
shows that neither the K k (SDYEGRLI, 50-57 [43]) nor the 
D b (366-374)  epitope  was  produced  after infection.  The 
CTLs used in this assay (F5 and a polyclonal anti-SDYEGRLI 
line) could nevertheless recognize T2 transfectants when pulsed 
with as little as 0.5  nM of the relevant peptide (Fig.  9 e). 
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Figure  9.  Sensitization  of target cells with L+NP. T2-D  b (a), T2-K  k 
(b), and TAP-competent  I~D  b cells, which express both D b and K k (c and 
d),  were  tested  for their ability  to present  peptide  antigen to clone F5 
(a and c) and a KLrestricted  polyclonal CTL line raised against NP50-57 
(SDYEGRLI, b and d) after infection with recombinant vaccinias encoding 
L+NP (e), I~NP (m), L+IMP (A),  or HIV-pol (V).  (e) In addition, 
the sensitivity  of each of these CTLs (assayed at an E:T ratio  of 2:1 for 
F5- and 10:1 for the KLrestricted  CTL line) was tested on the appropriate 
T2 transfectant  pulsed with synthetic  peptides ASNENMDAM (e) and 
SDYEGRLI (m). 
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Our results show that proteases in the ER (or other pre- 
Golgi compartments) can trim a precursor to a short peptide 
epitope that is optimal for presentation at the cell surface, 
as postulated by Falk et al.  and Rotzschke et al.  (3,  11). 
These results raise the possibility that the enzymatic pro- 
cessing of intracellular antigens could continue in the same 
intracellular compartment as that in which peptide binding 
to MHC class I molecules occurs. The natural substrates for 
ER proteases could therefore be longer peptides, generated 
in the cytosol, which are then delivered to the ER lumen 
by the TAP complex. 
Recent work has demonstrated a physical association be- 
tween class I molecules and the TAP complex in the ER (44, 
45).  The results of this study show that appropriate trim- 
ming and loading of peptides into class I molecules and their 
presentation at the cell surface can occur in the absence of 
the TAP complex, implying that contact of class I with TAP 
molecules is not essential for presentation of antigen. 
Peptides  encoded by  the  minigenes  L+M364-374  and 
L+M366-374  (being only 23-26 amino acids) are unlikely 
to be synthesized on rough ER and are more likely to be 
posttranslationally  translocated in a leader-dependent way (46). 
By studying the trimming of NH2-terminal extended pep- 
tides only, we were able to rule out any effect of cytosolic 
proteases,  to which the gene products were undoubtedly ex- 
posed, since trimming of the NH2 terminus would destroy 
the signal sequence and COOH-terminal trimming would 
lead to peptides that eluted with unique retention times when 
analyzed by RPLC.  Having also ruled out artifacts such as 
extracellular proteolysis in vitro and demonstrated that the 
leader-dependent generation of CTL epitopes is BFA sensi- 
tive and cloroquine insensitive, it is most likely that the trim- 
ming we have observed occurred in a pre-Golgi compartment 
of the infected cells. 
It is therefore possible to envisage a situation in which cyto- 
solic proteases generate fairly large peptide fragments from 
denatured proteins in the cytosol, which are then transported 
into the lumen of the ER by the TAP heterodimer. Enzymes 
in the ER could then trim longer precursor peptides in order 
to optimize the NH2 termini for class I binding. The possi- 
bility that COOH-terminal trimming can occur in the ER 
cannot be ruled out, although experiments by Eisenlohr et 
al.  (25) have implied that COOH-terminal trimming of a 
particular Kd-restricted epitope was not detectable. 
We have also found that the 170-amino acid IMP frag- 
ment of NP could be processed in the ER via a BFA-sensitive, 
chloroquine-insensitive pathway and also gave rise to the op- 
timal nonameric epitope NP366-374. This result established 
that up to 40 amino acids can be removed from between the 
signal sequence and the epitope. In addition to the removal 
of 40 amino acids from the NH2 terminus, 120 amino acids 
must also be removed from the COOH  terminus for this 
epitope to be produced. The L+IMP construct, being 170 
amino acids, is more likely to be cotranslationally transported 
into the ER than its shorter counterparts (46). It is possible, 
therefore, that proteases that are normally present in the ER 
are capable of degrading IMP in such a way as to reveal the 
correct COOH-terminal amino acid (Met-374) of the Db-re  - 
stricted epitope, as well as being able to trim 40 amino acids 
from the NH2  terminus.  However, it is also possible  that 
some newly synthesized IMP is exposed to cytosolic proteases, 
which trim the COOH terminus before transport into the ER. 
The ability of ER proteases to degrade full-length NP ex- 
pressed with a leader sequence revealed that this construct 
was a poor substrate, despite the synthesis of easily detect- 
able amounts of the L+ NP construct. The loss of presenta- 
tion could be due to an increase in the stability of NP when 
expressed  as a full-length protein.  NP might be stabilized 
in the ER as a result of conformational factors, or as a result 
of its glycosylation. Our results with influenza HA suggest 
that the latter may be the more likely, since neither the full- 
length HA, nor a truncated polypeptide (which would not 
be expected to adopt the same tertiary structure) gave rise 
to a Kk-restricted epitope in T2-K  k cells. Both these poly- 
peptides contain glycosylation sites. 
These results address the general issue of glycoprotein degra- 
dation in the ER and the ability of these degradation prod- 
ucts to assemble with class I molecules. Glycoprotein-derived 
CTL epitopes have been described, but the role of ER pro- 
teases in their generation is unclear. Townsend et al. (13) have 
shown that  a Kk-restricted HA epitope can be efficiently 
generated in a leader-independent way, suggesting that a frac- 
tion of this glycoprotein is released from ribosomes into the 
cytoplasm and exposed to cytosolic proteases.  Indeed, in this 
study, we have shown that the same epitope cannot be gener- 
ated in the ER, indicating that HA may be processed exclu- 
sively  in  the  cytosol.  The  same  may  be  true  of  other 
glycoprotein-derived CTL epitopes. Similar to our observa- 
tions with influenza HA, measles F protein cannot be presented 
to B27-restricted CTLs by infected T2-B27,  which lacks a 
functional TAP complex, even though it is readily presented 
by TAP-competent cells (47). Nevertheless, Hammond et al. 
(48) have recently demonstrated the ability of T2 cells to pro- 
cess HIV-1  gp120 in a leader-dependent way, giving rise to 
an HLA-A3-restricted epitope, suggesting that this peptide 
was generated by enzymes in the ER.  This may be a rela- 
tively infrequent  occurrence and  would  explain  why the 
majority of CTL epitopes described to date appear to be de- 
rived from proteins that do not enter the secretory pathway; 
it is supported by our observation that neither of the NP 
epitopes we studied could be generated in the ER. The im- 
plication is therefore that glycoproteins may be sheltered from 
the class I-associated processing pathway by their limited ex- 
posure to cytosolic proteases and by their relative resistance 
to proteolysis in the ER. 
Very little is known about ER resident proteases.  The best 
studied to date is leader peptidase, which cleaves the ER trans- 
location signal sequence from type 1 glycoproteins and has 
a well-defined specificity, cleaving after A, G, S, T, or C, in 
the general motif (A/G/S/T/C/L/WI)X(A/G/S/T/C)  (46). 
Peptides derived from leader sequences,  generated by the ac- 
tion of leader peptidase have been identified bound to HLA- 
1488  Antigen  Processing in the Endoplasmic Reticulum A2 in normal and TAP-defective cell lines (49). However, the 
specificity of this enzyme makes it unlikely that it is respon- 
sible for the NH2-terminal trimming observed in our experi- 
ments, since the sequences immediately preceding 366-374 
in either L+ M366-374 (MQI) or L+ M364-374 (DAM) do 
not contain a motif susceptible to recognition by leader pep- 
tidase. The involvement of leader peptidase in trimming the 
NH2 terminus of L+IMP and L+NP is even less likely. 
Selective, rapid degradation of incompletely assembled mul- 
tichain glycoproteins has been described for TCR o~ and 
and CD38 (50,  51). These polypeptides contain structural 
elements in their transmembrane domains that predispose them 
to proteolysis in the ER if they are not masked by multisubunit 
assembly. Although none of our L+  constructs contain this 
motif, the enzymes responsible for their degradation may be 
the same as those recruited for the degradation of TCR chains. 
Recently, Wileman et al. (52) have shown that targetted degra- 
dation of TCR chains in the ER can be inhibited by inhibi- 
tors of cysteine proteases and not by specific  inhibitors of tryp- 
sinlike  serine  proteases.  The degradation of many other 
incompletely assembled or misfolded proteins in the ER has 
been investigated, and the involvement of calcium-dependent 
proteases (53) and TLCK-inhibitable serine proteases (54) has 
been implicated in the proteolysis of two of these.  It there- 
fore appears that all classes of protease have been identified 
in association  with the ER. It remains to be seen which of 
these activities, if any, are responsible for generating peptides 
suitable for assembly with class I MHC. In addition, the pos- 
sibility that the ER is subdivided into functionally special- 
ized compartments (55),  with distinct regions for special- 
ized proteolysis,  is intriguing. 
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